Grade My Investments
HomeFree Stock Grades › LUCY

Lucyd, Inc (LUCY) Stock Grade

LUCY · Healthcare

A+
Grade updated: August 27, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$5.9M
P/E Ratio
Revenue Growth (YoY)
+62.7%
Net Margin
-285.2%
Return on Equity
Dividend Yield
None

About Lucyd, Inc's fundamentals

Lucyd, Inc is a micro-cap medical instruments and supplies company with a market capitalization of $7.1 million that has demonstrated strong revenue growth of 62.7% year-over-year. However, the company is currently unprofitable, reporting a net loss in its latest annual statement with a net margin of -285.2%, indicating it is spending significantly more than it generates in revenue. The company does not pay a dividend and cannot be evaluated on traditional profitability metrics like P/E ratio or return on equity due to its loss-making status.

Track LUCY free — no credit card required. Live grade + monthly AI report →